20200 West Dixie Hwy, Suite 808D, Miami, FL 33180
|
No Insurance Accepted
Female Sexual Wellness & Clinical Care

Low Libido in Women:
Common Causes and Treatment Options

A compassionate, physician-guided look at responsive desire, hormonal shifts, medical evaluation, and individualized treatments in Miami.

October 20, 2026 • Dr. Nina Gupta, MD, ABAARM, FAARM
Woman discussing low libido concerns during a private physician consultation in Miami

A change in sexual desire can be difficult to understand, especially when it happens gradually. You may still feel emotionally connected to your partner but find that intimacy rarely comes to mind. Perhaps you want to feel interested in sex, yet stress, exhaustion, hormonal changes, or physical discomfort seem to get in the way. Whatever your experience looks like, low libido in women is a common concern that deserves thoughtful, personalized care rather than judgment or pressure.

Sexual desire is influenced by much more than hormones. Sleep, emotional well-being, relationships, medications, physical health, and life transitions can all play a role. Sometimes several factors overlap, making it difficult to identify one clear cause without professional guidance. The encouraging news is that a range of treatment options may help, depending on what is contributing to your symptoms and what you hope to change.

For women seeking female sexual wellness in Miami, understanding the available options is a useful first step toward an informed conversation with a qualified healthcare professional. Treatment might involve addressing vaginal dryness, reviewing medications, exploring counseling, evaluating menopause symptoms, or considering prescription therapies for a diagnosed sexual desire disorder.

Clinical Overview: Female Desire

Key Takeaway: Low libido in women is rarely caused by a single isolated hormone deficiency. It involves a complex interplay of physical comfort, responsive desire, mental load, sleep, medications, and life transitions. A comprehensive clinical evaluation with a physician distinguishes between desire disorders (HSDD), arousal barriers, and localized discomfort like vaginal dryness, ensuring your treatment plan matches your specific biological and personal needs.

This guide explains the common causes of decreased sex drive, what to expect during a medical evaluation, and the evidence and limitations surrounding different treatment approaches, including hormone therapy and the O-Shot.


What Counts as Low Libido in Women?

Libido refers to sexual desire or interest. It can include thoughts about intimacy, curiosity about sexual activity, a wish for physical closeness, or an interest that develops during affectionate contact. However, there is no universal standard for how frequently a woman should want sex. Sexual desire differs from person to person and can change throughout life, so comparing your experience with a partner, friend, or online description may not provide a meaningful answer.

Some women experience spontaneous desire, meaning sexual interest appears without an obvious trigger. Others experience responsive desire, in which interest develops after welcome affection, emotional connection, or stimulation. Neither pattern is automatically healthier than the other. Responsive desire is a recognized pattern of sexual response, but it never means you should engage in unwanted activity or continue when something feels uncomfortable.

A lower level of desire is not necessarily a medical disorder. A clinician may consider hypoactive sexual desire disorder (HSDD) when a persistent reduction in sexual interest causes significant personal distress and meets appropriate diagnostic criteria. The assessment also considers other possible explanations, including medication effects, health conditions, psychological concerns, and relationship circumstances.

Understanding responsive desire and sexual health

Sexual health involves more than how often you think about sex. Desire, physical arousal, vaginal comfort, sensation, and orgasm are related but distinct aspects of the experience. You might feel emotionally interested but experience dryness or pain, for example, or you might enjoy intimacy without experiencing spontaneous sexual thoughts beforehand.

Recognizing these differences can help you describe your concerns more accurately. Rather than simply saying that your libido is low, consider whether you have noticed fewer sexual thoughts, less interest in initiating intimacy, discomfort during intercourse, difficulty becoming aroused, or changes in orgasm. You do not need to diagnose yourself; these observations simply give your healthcare professional a clearer starting point.

Your personal goals matter, too. You may want to understand why your desire has changed, feel more comfortable during intimacy, or reduce the distress surrounding a difference in desire between you and your partner. A helpful treatment plan starts with what is troubling you rather than an arbitrary expectation about how often sex should happen.


Common Causes of Low Libido in Women

There is rarely one explanation that applies to every woman experiencing decreased sexual desire. For some, the main contributor is persistent stress or poor sleep. For others, menopause-related discomfort, medication side effects, depression, chronic illness, or relationship difficulties may be more significant. It is also possible for several of these factors to interact.

For example, vaginal dryness can make intercourse uncomfortable. Anticipating discomfort may lead someone to avoid intimacy, and that avoidance can gradually affect sexual interest. Similarly, ongoing sleep disruption can contribute to fatigue, irritability, and reduced emotional availability, leaving little energy for physical closeness. These examples illustrate why treating a single symptom may not address the entire concern.

Understanding the timing of your symptoms is often useful. Did your interest change after childbirth, during perimenopause, following a medication adjustment, or during a particularly stressful period? Did discomfort appear before your desire declined, or did both changes occur together? These details can help guide a more targeted evaluation.

Stress, fatigue, and mental overload

Daily responsibilities can have a surprisingly strong influence on sexual desire. Work demands, financial concerns, caregiving, household tasks, interrupted sleep, and emotional strain can leave you feeling mentally occupied long after the day ends. When your attention is constantly focused on what needs to happen next, intimacy may feel like another responsibility instead of something enjoyable.

Mental health can also influence sexual interest. Anxiety may make it difficult to relax, while depression can affect motivation, pleasure, energy, and emotional connection. Previous distressing experiences or worries about body image and sexual performance may create additional barriers. These concerns deserve compassionate attention rather than assumptions that a person simply needs to try harder.

Practical changes can sometimes help when exhaustion and stress are important contributors. Protecting sleep, sharing responsibilities, allowing time for rest, and communicating about pressure-free affection may create more room for intimacy. Counseling or sex therapy can also help when anxiety, communication difficulties, or emotional distress play a role.

These approaches are not substitutes for medical assessment when physical symptoms are present. Instead, they are potential parts of a broader plan that considers your daily circumstances alongside your health.

Perimenopause and menopause

Perimenopause is the transition leading up to menopause, while menopause marks the end of menstrual periods after the appropriate period of time without menstruation. Hormonal changes during these stages can affect vaginal tissues, sleep, temperature regulation, and sexual comfort. Some women experience hot flashes or night sweats that interrupt sleep, while others notice dryness, irritation, or pain during intercourse.

When intimacy becomes uncomfortable, interest may naturally decline. This does not necessarily mean that the body has lost its capacity for sexual pleasure or that emotional attraction has disappeared. In many cases, addressing the physical symptoms can improve comfort and make intimacy feel more manageable.

Menopause affects women differently. Some experience substantial changes in sexual desire, while others notice little change or remain interested in sex throughout this stage of life. There is no single menopausal experience, and reduced libido should not automatically be attributed to age.

Treatment depends on the symptoms, medical history, and individual preferences. Vaginal moisturizers, lubricants, selected prescription treatments, and menopause hormone therapy for appropriate indications may be discussed with a clinician. Women exploring menopause care can learn more through the O-Shot Miami menopause care page and our guide on painful sex during perimenopause.

Postpartum changes and breastfeeding

The period following childbirth involves physical recovery, changing routines, and substantial emotional and practical adjustments. New parents may experience interrupted sleep, feeding schedules, fatigue, changes in body image, and less privacy. These factors can influence interest in intimacy even when a relationship remains loving and supportive.

Hormonal changes after delivery can also contribute to vaginal dryness, particularly during breastfeeding. Healing after childbirth, pelvic floor symptoms, and discomfort around a surgical incision or tear may affect physical comfort. If intimacy hurts, it is understandable that you might feel hesitant about trying again.

There is no universal timetable for the return of sexual desire after childbirth. Readiness can fluctuate, and the experience may differ between pregnancies or from one stage of postpartum recovery to another. Pressure to return to a previous level of sexual activity can make the experience more stressful.

A postpartum healthcare visit offers an opportunity to discuss pain, dryness, mood changes, and concerns about sexual health. Seek assessment when symptoms persist, interfere with daily life, or cause distress. If you are experiencing significant depression, anxiety, or thoughts of harming yourself, seek prompt professional support rather than assuming these feelings are simply part of the adjustment to parenthood.

Medications and underlying medical conditions

Certain medications can affect sexual desire, arousal, or orgasm. Some antidepressants are associated with sexual side effects, and other medicines may contribute depending on the drug, dose, and individual response. Chronic pain, ongoing illness, cancer treatment, and conditions that affect energy or emotional well-being can also influence sexual health.

The timing of a change may provide useful clues. If you noticed reduced desire after starting a medication or changing its dose, tell the prescribing clinician. Mention any other changes, such as fatigue, mood symptoms, sleep disruption, or difficulty reaching orgasm. These details help distinguish possible medication effects from other contributors.

Do not stop or reduce a prescribed medication without discussing it with your healthcare professional. An abrupt change can worsen the condition being treated or cause withdrawal symptoms. Depending on your circumstances, your clinician may consider an alternative medication, a different dose, a change in timing, or another strategy that balances benefits and side effects.

Medical conditions may warrant targeted evaluation when the history suggests a possible connection. For example, thyroid testing may be appropriate when symptoms point toward a thyroid problem. However, testing should be guided by the clinical picture rather than ordering every available hormone test automatically.

Pain, vaginal dryness, and relationship concerns

Physical discomfort can affect sexual desire in ways that are easy to overlook. Vaginal dryness, irritation, infections, skin conditions, and pelvic floor muscle problems can make certain forms of sexual activity uncomfortable. Pain may lead to anticipatory anxiety, causing someone to avoid intimacy even when they still want emotional closeness.

Relationship context matters as well. Unresolved conflict, a lack of privacy, difficulty communicating preferences, unequal responsibilities, or feeling pressured can affect interest. Sometimes the concern is not attraction itself but whether intimacy feels safe, comfortable, and mutually wanted.

These factors can occur together. A woman experiencing menopause-related dryness may also be dealing with stress, for instance, while a couple may find that physical discomfort has made communication more difficult. Treating the physical symptoms while addressing emotional concerns may be more effective than assuming there is one simple explanation.

Painful sex should not be dismissed as an inevitable part of aging or a problem that must be tolerated. The American College of Obstetricians and Gynecologists' guidance on painful sex provides additional evidence-based information about possible causes and seeking care.


What Happens During a Low Libido Evaluation?

Starting a conversation about sexual desire can feel uncomfortable, but you do not need specialized terminology to explain what is happening. A simple statement such as, "My interest in sex has changed, and it is bothering me," gives your healthcare professional a place to begin. Your concerns are a legitimate part of your overall health.

A clinician may ask when you first noticed the change, whether it happens in all situations, and how it affects your well-being. You might discuss your menstrual history, menopause symptoms, pregnancy or breastfeeding, medication use, sleep, mood, relationship circumstances, and any pain or dryness. You can also explain what you would like to improve and whether there are particular activities or situations that feel comfortable or uncomfortable.

An examination may be recommended when symptoms suggest a physical cause. For example, persistent pain, irritation, or unusual discharge may warrant an assessment of the affected area. Your clinician should explain why an examination is being recommended, what it involves, and what alternatives are available. You should be able to ask questions and provide informed consent.

Laboratory testing depends on your history and symptoms. Thyroid tests or other investigations may be appropriate when there are signs of an underlying medical condition. However, a broad hormone panel is not automatically necessary for every woman with low desire. In particular, a testosterone blood level alone cannot establish HSDD or explain every change in sexual interest.

A useful evaluation distinguishes between reduced desire and other concerns, such as pain, inadequate lubrication, difficulty with arousal, or changes in orgasm. The distinction matters because each concern may call for a different approach. The goal is not to force your experience into a diagnosis; it is to identify plausible contributors and develop a plan that reflects your needs.


Female Low Libido Treatment Options

Female low libido treatment should be guided by the likely cause, the level of distress, your medical history, and your personal preferences. There is no single medication, procedure, or lifestyle change that works for everyone. Some women benefit from addressing sleep and stress, while others need treatment for vaginal symptoms, a review of medications, counseling, or an assessment for a diagnosed desire disorder.

Treatment can also involve more than one approach. If menopause-related dryness and relationship stress are both contributing, addressing only one may leave the other unresolved. A clinician can help prioritize the options most likely to be useful and explain their expected benefits, limitations, costs, and risks.

Treatment Category Target Concern Clinical Approach Considerations
Lifestyle & Sex Therapy Stress, fatigue, communication, performance anxiety First-Line Behavioral Focuses on shared intimacy, sleep, and emotional safety without medical side effects
Moisturizers & Lubricants Vaginal dryness, friction, mild discomfort First-Line Nonhormonal Regular hydration (moisturizers) & acute use during intercourse (lubricants)
Local Vaginal Estrogen / DHEA Genitourinary Syndrome of Menopause (GSM), tissue atrophy Targeted Prescription Restores vaginal epithelial thickness and natural moisture with minimal systemic absorption
Prescription HSDD Therapies (Addyi / Vyleesi) Acquired, generalized Hypoactive Sexual Desire Disorder FDA-Approved Neurotransmitter modulators for premenopausal women; requires screening for blood pressure and interactions
Systemic Testosterone Therapy Postmenopausal HSDD after other causes ruled out Off-Label / Monitored Evidence-based for selected postmenopausal women; requires close monitoring; pellets not recommended by guidelines
Autologous PRP / O-Shot® Local sensation, lubrication, tissue repair, mild leakage Regenerative / Adjunctive Uses patient's own platelets; enhances tissue health; not a proven replacement for HSDD care

Lifestyle changes, counseling, and sex therapy

When stress, fatigue, or competing responsibilities contribute to reduced desire, practical adjustments may make a difference. Improving sleep where possible, sharing caregiving and household tasks, and making space for relaxation can reduce some of the barriers that leave intimacy feeling exhausting. These changes are intended to support your well-being, not create another checklist of obligations.

Communication can be equally important. You and your partner may benefit from discussing which kinds of affection feel welcome, what causes pressure, and whether you want intimacy to follow a particular pattern. Touch does not have to lead to sex, and a mutually comfortable approach can help reduce performance expectations.

Counseling or sex therapy may be helpful when anxiety, body-image concerns, relationship conflict, or distressing experiences affect sexual well-being. A qualified therapist can help you explore patterns of communication and develop strategies suited to your situation. Couples therapy may be useful when both partners want to work on shared concerns, although individual therapy can also be appropriate.

Psychological support does not mean that symptoms are imaginary. Sexual health is influenced by both physical and emotional factors, and addressing one does not invalidate the other. Counseling can be used alongside medical care when that combination fits your needs.

Treatments for vaginal dryness and painful intimacy

When dryness contributes to discomfort, lubricants and vaginal moisturizers may help. Lubricants are generally used during sexual activity to reduce friction, while vaginal moisturizers are used regularly to relieve ongoing dryness. Choosing a product that suits your body and any medical considerations can improve comfort, but persistent pain deserves assessment rather than repeated attempts to manage it alone.

For some women experiencing menopause-related genitourinary symptoms, prescription options may include low-dose vaginal estrogen, vaginal prasterone (DHEA), or oral ospemifene. The suitability of each option depends on your symptoms, medical history, and other factors. Women with a history of hormone-sensitive cancer should discuss their options with their treating team and relevant specialists (read our clinical review on the O-Shot after breast cancer).

Pelvic floor physical therapy may be appropriate when pelvic floor muscle dysfunction contributes to pain. Depending on the underlying issue, treatment may focus on muscle relaxation, coordination, movement, and strategies to reduce discomfort. A clinician can help determine whether this approach is relevant.

These treatments primarily address physical symptoms such as dryness and pain; they are not interchangeable with treatment for HSDD. However, improving comfort may remove one barrier to sexual interest and make intimacy more enjoyable. The best option is the one that fits the underlying problem and is medically appropriate for you.

Prescription medications for hypoactive sexual desire disorder

Prescription medicines may be considered for selected women who meet the criteria for HSDD. They are not general-purpose libido boosters, and they are not suitable for every case of reduced sexual interest. Before prescribing treatment, a clinician should assess whether other medical, psychological, medication-related, or relationship factors better explain the symptoms.

Flibanserin (Addyi) is a daily oral prescription medicine used for eligible premenopausal women with acquired, generalized HSDD. Acquired means the problem developed after a period of previously satisfactory sexual desire, while generalized means it occurs across situations rather than in only one setting. Eligibility, including age-related considerations, should be confirmed against current prescribing information and the patient's circumstances. Flibanserin can cause side effects such as dizziness, sleepiness, nausea, and low blood pressure, and it carries a risk of fainting. Alcohol-related precautions, interactions with other medicines (such as CYP3A4 inhibitors), and liver disease require careful review.

Bremelanotide (Vyleesi) is an as-needed subcutaneous prescription injection for eligible premenopausal women with acquired, generalized HSDD, administered at least 45 minutes before anticipated intimacy. It works as a melanocortin receptor agonist. It may cause nausea (which can be prominent during initial doses) and can temporarily raise blood pressure. It is contraindicated in people with uncontrolled hypertension or known cardiovascular disease, making thorough medical screening essential.

Neither medication guarantees improvement, and neither is intended to treat every form of decreased sex drive. A prescribing clinician should discuss expected benefits, risks, other medications, pregnancy or breastfeeding considerations, and follow-up. Current prescribing information should always be checked before making treatment decisions because approved indications and safety guidance can change.

Individualized hormone treatment

Hormonal changes can contribute to sexual symptoms, but hormone treatment is not automatically the answer to low libido. Menopause hormone therapy may be appropriate for selected patients with vasomotor symptoms such as hot flashes or night sweats, depending on their health history and treatment goals. Its role should be considered in the context of the specific symptoms it is intended to address.

For selected postmenopausal women with HSDD, carefully monitored systemic testosterone may be considered after a thorough assessment of other contributors, following the ISSWSH Clinical Practice Guideline. In the United States, this use is off-label. A clinician should discuss the evidence, uncertainties, potential adverse effects, and monitoring requirements before treatment begins.

Possible side effects of excessive testosterone exposure include acne, unwanted facial hair growth, voice deepening, and lipid alterations. Long-term safety data remain limited, so treatment requires baseline testing and regular physician oversight to keep levels within the normal premenopausal female physiologic range. Major clinical guidance does not recommend testosterone pellets for HSDD because they can produce supraphysiologic levels that are difficult to control or reverse if adverse effects occur.

A testosterone result alone does not diagnose HSDD or prove that testosterone treatment is needed. If hormone treatment is being considered, the decision should be based on your symptoms, relevant medical history, evidence-based guidance, and a discussion of potential benefits and risks. You can learn more about arranging an individualized discussion through our hormone evaluation and optimization page.


Can the O-Shot Help With Low Libido?

The O-Shot® is a procedure that uses platelet-rich plasma, commonly called PRP, prepared from a person's own blood and injected into selected intimate tissues (near the clitoris and anterior vaginal wall) after local numbing. Some women explore the procedure because of concerns involving sensation, comfort, lubrication, or orgasm. These physical issues can overlap with sexual desire, but they are not the same problem, and each requires a distinct medical evaluation.

The scientific evidence for PRP procedures in female sexual health is still developing. A randomized controlled trial published in 2026 (PubMed: 41855531) investigated vaginal PRP injections for sexual function. The study reported greater improvement in overall sexual-function scores (FSFI) after vaginal PRP among premenopausal women without severe baseline sexual dysfunction. However, the study observed that the desire subscale did not show a statistically significant difference between the PRP and control groups. These findings should be interpreted cautiously rather than treated as proof that PRP reliably cures or enhances sexual desire.

A study of one PRP approach does not automatically validate every branded procedure or establish its effectiveness for every sexual health concern. The O-Shot has not been established as a proven treatment for HSDD, and it should not be presented as a replacement for evidence-based care. Its regulatory status and the evidence supporting specific claims should be verified with a qualified clinician before treatment.

Patients considering an injection-based procedure should ask about the quality of the available evidence, the expected degree of improvement, the clinician's training, the total cost (transparently $1,500 at O-Shot Miami), and the possibility that symptoms may not improve. Potential injection-related risks can include temporary pain, swelling, bruising, and minor infection. Ask how these risks are minimized and what follow-up is provided.

For women interested in female sexual wellness in Miami, a physician-led consultation can help distinguish between concerns about desire, arousal, comfort, and orgasm. That distinction makes it easier to compare established treatments with newer procedures whose benefits remain uncertain. An informed decision should reflect your health needs and preferences, not a promise of guaranteed results. Read our comprehensive analysis on who is a good candidate for the O-Shot.


When Should You Seek Medical Help?

Consider scheduling an appointment if decreased sexual desire persists, causes personal distress, affects your quality of life, or begins after a medication change. You do not need to wait until the concern becomes severe or begins creating strain in your relationship. A medical consultation can help you understand possible causes even if you are not ready to pursue a particular treatment.

Seek medical assessment for:

  • Painful intercourse (dyspareunia) or persistent burning during or after intimacy
  • Persistent or worsening vaginal dryness and irritation
  • Unexplained bleeding after intercourse or between menstrual cycles
  • Unusual vaginal discharge, pelvic pain, or a new genital skin lesion
  • Severe mood symptoms, overwhelming fatigue, or depression that interferes with daily life

These symptoms may indicate conditions that need specific diagnostic testing and medical treatment, and they should not automatically be attributed to menopause or ordinary aging.

Before your appointment, it may help to note when the change began, whether it is constant or situation-specific, what medications and supplements you take, and whether you have noticed other physical or emotional symptoms. Remember that seeking help does not commit you to medication, hormone therapy, or a procedure. You can ask questions, discuss alternatives, and take time to decide. The purpose of care is to help you make an informed choice that respects your health, comfort, and priorities.

Private Physician Consultation in Miami

Schedule a discreet, personalized evaluation with Dr. Nina Gupta to explore your symptoms, hormonal health, and evidence-based treatment options.

Book Your Private Consultation

Frequently Asked Questions About Low Libido in Women

1. Is low libido in women always a hormone problem?

No. Hormonal changes may contribute to decreased sexual desire, but stress, sleep disruption, medication effects, pain, mood, and relationship circumstances can also play a role. Some women experience several contributing factors at the same time. A clinical assessment can help identify which possibilities deserve attention before treatment is chosen.

2. Can I have low libido with normal hormone tests?

Yes. Sexual desire is influenced by many factors beyond the results of a blood test. Normal hormone levels do not invalidate your symptoms, and they do not rule out treatable contributors such as pain, medication side effects, stress, or relationship difficulties. Testing should be selected according to your history and symptoms rather than used as the sole measure of sexual health.

3. What is the best female low libido treatment?

There is no single treatment that is best for everyone. The appropriate option depends on whether the main concern involves desire, vaginal dryness, painful intercourse, menopause symptoms, medication effects, or a combination of factors. Depending on the findings, care may include counseling, targeted treatment for physical symptoms, medication review, or prescription therapy for eligible patients with HSDD.

4. Does low libido mean I need testosterone?

No. Testosterone is not appropriate for every woman experiencing reduced sexual desire, and a blood testosterone level alone cannot establish the diagnosis of HSDD. Carefully monitored testosterone may be considered for selected postmenopausal women with HSDD after other contributors have been assessed. A clinician should explain the evidence, off-label status in the United States, possible side effects, and monitoring requirements.

5. Can the O-Shot replace treatment for HSDD?

No. PRP procedures such as the O-Shot have not been established as replacements for evidence-based HSDD care. Research into their effects on female sexual function remains limited, and findings about overall sexual function do not necessarily demonstrate a meaningful improvement in desire. Discuss your specific symptoms and the evidence for each option with a qualified healthcare professional before deciding.


Conclusion: Finding the Right Approach to Female Sexual Wellness

Low libido in women can develop for many reasons, from stress and sleep disruption to menopause-related symptoms, medication effects, pain, and emotional concerns. A change in desire does not automatically indicate a disorder, and there is no universal level of sexual interest that every woman should experience. What matters is understanding your own experience, identifying what is causing distress, and deciding whether you would like support.

The most useful first step is a thoughtful evaluation that considers your physical health, emotional well-being, medications, and personal goals. Depending on the findings, treatment may involve improving comfort, addressing underlying medical issues, exploring counseling, reviewing prescription medicines, or considering appropriate treatment for HSDD. Hormone therapies and procedures such as the O-Shot require particular care in evaluating the evidence, potential benefits, limitations, and risks.

If you are looking for female sexual wellness care in Miami, O-Shot Miami offers an opportunity to discuss concerns involving desire, comfort, sensitivity, and menopause with a physician. A consultation can help clarify which options may be appropriate for your circumstances without assuming that any one procedure or medication is the answer.

Call 305-916-1454 or request a confidential consultation with O-Shot Miami. Taking the first step can help you move from uncertainty toward a clearer understanding of your sexual health and the options available to you.

Medical Disclaimer: This article is for general educational purposes and does not replace an individualized medical evaluation. Treatment decisions should be made with a qualified healthcare professional. Dr. Gupta confirms the clinic's screening, evaluation, and evidence-based protocols.

Medical References

  1. American College of Obstetricians and Gynecologists (ACOG). Your Sexual Health.
  2. National Institute on Aging (NIA). Sex and Menopause: Treatment for Symptoms.
  3. National Institute on Aging (NIA). Sexuality and Intimacy in Older Adults.
  4. American College of Obstetricians and Gynecologists (ACOG). When Sex Is Painful.
  5. International Society for the Study of Women's Sexual Health (ISSWSH). Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. J Sex Med.
  6. U.S. Food and Drug Administration (FDA). Addyi (flibanserin) Prescribing Information.
  7. National Library of Medicine / DailyMed. Vyleesi (bremelanotide) Prescribing Information.
  8. Vaginal Injection of Platelet-Rich Plasma for Sexual Function: A Randomized Controlled Trial. Obstetrics & Gynecology. 2026. PubMed: 41855531.

Private Physician Consultation

Discuss your sexual wellness, hormonal symptoms, and personalized care options with Dr. Nina Gupta, MD.

Book Consultation
Dr. Nina Gupta

Dr. Nina Gupta, MD

With over 37 years of clinical medical experience, Dr. Nina Gupta (ABAARM, FAARM) specializes in women's intimate wellness, hormone optimization, and regenerative therapies.

REQUEST A COMPLIMENTARY CALL-BACK

Have a Question About a
Treatment?

Request a complimentary call-back from Dr. Nina Gupta's team. We'll answer your preliminary questions and help you understand our treatment options at no cost.

Medical Appointments & Fees: While phone inquiries are complimentary, clinical evaluations carry a fee. The O-Shot treatment package is $1,500 (includes Labia Wing Lift when appropriate); the comprehensive initial hormone optimization consultation with diagnostic bloodwork is $750.

Please do not submit confidential medical records or sensitive health details through this website form. By submitting, you acknowledge our Privacy Policy.